Atlas Trials

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

RecordFirmDate
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults (NCT04530565)National Cancer Institute (NCI)2021-01-25
Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (NCT02484430)National Cancer Institute (NCI)2017-04-06
Personalized NK Cell Therapy in CBT (NCT02727803)M.D. Anderson Cancer Center2016-05-19
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia (NCT02143414)National Cancer Institute (NCI)2015-06-30
Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML (NCT02311998)M.D. Anderson Cancer Center2015-04-16
Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia (NCT01424982)M.D. Anderson Cancer Center2011-10-05
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia (NCT01371630)M.D. Anderson Cancer Center2011-08-26

Track B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 automatically

Every clearance here is in the API, with alerts when new ones post.